Impact of Etiology, Thrombectomy Techniques, and Lesion Localization on Endovascular Treatment Success in Acute Basilar Artery Occlusion: A Single-Center Retrospective Study
Halil Alper Eryilmaz, Sena Boncuk Ulaş, Bilgehan Atılgan Acar
{"title":"Impact of Etiology, Thrombectomy Techniques, and Lesion Localization on Endovascular Treatment Success in Acute Basilar Artery Occlusion: A Single-Center Retrospective Study","authors":"Halil Alper Eryilmaz, Sena Boncuk Ulaş, Bilgehan Atılgan Acar","doi":"10.1002/brb3.70612","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Basilar artery occlusion (BAO) is a rare but severe form of large vessel occlusion associated with high rates of mortality and morbidity. Endovascular treatment (EVT) has become the primary therapeutic option; however, its efficacy and procedural risks in BAO remain controversial. This study aims to evaluate the clinical and procedural outcomes of EVT in BAO and to compare these results across different etiological subgroups.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We retrospectively analyzed 23 patients who underwent EVT for BAO between December 2019 and December 2024. Demographic data, procedural times, recanalization success rates, complications, and functional outcomes assessed by the Modified Rankin Scale (mRS) at three months were evaluated. The patients were categorized into three groups based on the etiology: large artery atherosclerosis, cardioembolism, and undetermined causes.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Successful recanalization (mTICI 2c-3) was achieved in 100% of cases. The mean symptom-to-recanalization time was the longest in the large artery atherosclerosis group (345 ± 165.38 min). At the three-month follow-up, 47.8% of patients had a good functional outcome (mRS 0–2), and 34.1% achieved an excellent outcome (mRS 0–1). The cardioembolism group had lower mean mRS scores compared to other groups. Intracranial hemorrhage occurred in 13% of cases, with 8.7% classified as symptomatic.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The mean 3-month mRS scores were lower in the cardioembolic etiology group. Although the combined technique group had longer recanalization times, they exhibited lower mean 3rd month mRS scores. As the number of randomized controlled trials increases, it is expected that EVT in BAO will be recommended with higher levels of evidence in the guidelines.</p>\n </section>\n </div>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"15 6","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/brb3.70612","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain and Behavior","FirstCategoryId":"102","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/brb3.70612","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Basilar artery occlusion (BAO) is a rare but severe form of large vessel occlusion associated with high rates of mortality and morbidity. Endovascular treatment (EVT) has become the primary therapeutic option; however, its efficacy and procedural risks in BAO remain controversial. This study aims to evaluate the clinical and procedural outcomes of EVT in BAO and to compare these results across different etiological subgroups.
Methods
We retrospectively analyzed 23 patients who underwent EVT for BAO between December 2019 and December 2024. Demographic data, procedural times, recanalization success rates, complications, and functional outcomes assessed by the Modified Rankin Scale (mRS) at three months were evaluated. The patients were categorized into three groups based on the etiology: large artery atherosclerosis, cardioembolism, and undetermined causes.
Results
Successful recanalization (mTICI 2c-3) was achieved in 100% of cases. The mean symptom-to-recanalization time was the longest in the large artery atherosclerosis group (345 ± 165.38 min). At the three-month follow-up, 47.8% of patients had a good functional outcome (mRS 0–2), and 34.1% achieved an excellent outcome (mRS 0–1). The cardioembolism group had lower mean mRS scores compared to other groups. Intracranial hemorrhage occurred in 13% of cases, with 8.7% classified as symptomatic.
Conclusion
The mean 3-month mRS scores were lower in the cardioembolic etiology group. Although the combined technique group had longer recanalization times, they exhibited lower mean 3rd month mRS scores. As the number of randomized controlled trials increases, it is expected that EVT in BAO will be recommended with higher levels of evidence in the guidelines.
期刊介绍:
Brain and Behavior is supported by other journals published by Wiley, including a number of society-owned journals. The journals listed below support Brain and Behavior and participate in the Manuscript Transfer Program by referring articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Brain and Behavior.
* [Acta Psychiatrica Scandinavica](https://publons.com/journal/1366/acta-psychiatrica-scandinavica)
* [Addiction Biology](https://publons.com/journal/1523/addiction-biology)
* [Aggressive Behavior](https://publons.com/journal/3611/aggressive-behavior)
* [Brain Pathology](https://publons.com/journal/1787/brain-pathology)
* [Child: Care, Health and Development](https://publons.com/journal/6111/child-care-health-and-development)
* [Criminal Behaviour and Mental Health](https://publons.com/journal/3839/criminal-behaviour-and-mental-health)
* [Depression and Anxiety](https://publons.com/journal/1528/depression-and-anxiety)
* Developmental Neurobiology
* [Developmental Science](https://publons.com/journal/1069/developmental-science)
* [European Journal of Neuroscience](https://publons.com/journal/1441/european-journal-of-neuroscience)
* [Genes, Brain and Behavior](https://publons.com/journal/1635/genes-brain-and-behavior)
* [GLIA](https://publons.com/journal/1287/glia)
* [Hippocampus](https://publons.com/journal/1056/hippocampus)
* [Human Brain Mapping](https://publons.com/journal/500/human-brain-mapping)
* [Journal for the Theory of Social Behaviour](https://publons.com/journal/7330/journal-for-the-theory-of-social-behaviour)
* [Journal of Comparative Neurology](https://publons.com/journal/1306/journal-of-comparative-neurology)
* [Journal of Neuroimaging](https://publons.com/journal/6379/journal-of-neuroimaging)
* [Journal of Neuroscience Research](https://publons.com/journal/2778/journal-of-neuroscience-research)
* [Journal of Organizational Behavior](https://publons.com/journal/1123/journal-of-organizational-behavior)
* [Journal of the Peripheral Nervous System](https://publons.com/journal/3929/journal-of-the-peripheral-nervous-system)
* [Muscle & Nerve](https://publons.com/journal/4448/muscle-and-nerve)
* [Neural Pathology and Applied Neurobiology](https://publons.com/journal/2401/neuropathology-and-applied-neurobiology)